Phase Genomics
Seattle, US · Founded 2015 · Delaware corporation · 14 employees on LinkedIn · 4 known investors
Find your way into Phase Genomics
367 people in our graph share verified history with the Phase Genomics team — schools, employers, funds. One of them is your warm intro.
Wesley Chanunlockedknows Shawn Sullivan · together at Massachusetts Institute of Technology (overlapped)
×10knows the team · via Massachusetts Institute of Technology
knows the team · via Phase Genomics
Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.
Founders & leadership
Phase Genomics was founded in 2015 by Ivan Liachko and Shawn Sullivan.
IL
Ivan LiachkoinCo-founder & CEOIvan Liachko is a molecular geneticist and genomicist with more than 20 years of experience in wet-lab and computational biology. He is the founder and CEO of Phase Genomics, a Seattle-based company established in 2015 that develops proximity-ligation-based long-range genome sequencing technology and computational tools for life sciences research.
SS
Shawn SullivaninCo-Founder and AdvisorShawn Sullivan is co-founder and former CTO of Phase Genomics, a biotech company developing genome sequencing technology. He previously worked as a software engineer at Microsoft on Office products.
Investors · 4
Funding
SEC filings, press & company announcements$7.3M disclosed across 3 rounds · 2017–2024
- $1.5MraisedMar 2024 · 2 sources
Bill & Melinda Gates Foundation
Source ↗
▶$4.8MraisedMar 2023 · 13 investors · BiotechnologyRule 506(b)
▶$4.8MraisedMar 2023 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn SullivanExecutive Officer, Promoter
- Ivan LiachkoExecutive Officer, Director, Promoter
- Kayla YoungExecutive Officer
- Offering amount
- $6.6M
- Amount sold
- $4.8M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedNov 2017 · 4 investors · BiotechnologyRule 506(b)
▶$1MraisedNov 2017 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ivan LiachkoExecutive Officer, Director, Promoter
- Shawn SullivanExecutive Officer, Promoter
- Offering amount
- $1.4M
- Amount sold
- $1M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
IDbyDNA48 shared keywordsScalable, high throughput DNA sequencing platforms.
Oup32 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Pacb28 shared keywordsPacific Biosciences manufactures consumables and reagent kits for long-read DNA and RNA sequencing platforms, serving genomics research and diagnostics labs.
Genomics Plc25 shared keywordsGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
Polaris Genomics24 shared keywordsPolaris Genomics is a Veteran-owned biotech startup mapping molecular biomarkers to develop objective, biologically-based diagnostics and novel therapeutics for mental health and neuropsychiatric conditions such as PTSD. It combines genomics and AI to advance precision mental health care.
Companies competing with Phase Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Phase Genomics do?
- Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.
- Who founded Phase Genomics?
- Phase Genomics was founded by Ivan Liachko, Shawn Sullivan in 2015.
- Who are Phase Genomics's investors?
- Phase Genomics's investors include Congruent Ventures, Hemi Ventures, Llc, Alliance of Angels, Bill & Melinda Gates Foundation.
- How much funding has Phase Genomics raised?
- Phase Genomics has disclosed $7.3M raised across 3 rounds.
- Where is Phase Genomics headquartered?
- Phase Genomics is headquartered in Seattle, US.